Marcel Krepstakies

发表

Excision of HIV-1 Proviral DNA by Recombinant Cell Permeable Tre-Recombinase

J. Hauber, F. Buchholz, E. Hildt, 2012, PloS one.

In silico Design, Synthesis, and Screening of Novel Deoxyhypusine Synthase Inhibitors Targeting HIV‐1 Replication

J. Hauber, M. Rarey, C. Meier, 2014, ChemMedChem.

Rational Drug Design—Screening and Synthesis of Potential Deoxyhypusine Synthase Inhibitors Targeting HIV-1 Replication

J. Hauber, M. Rarey, C. Meier, 2010 .

A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.

J. Hauber, K. Brandenburg, T. Gutsmann, 2012, The Journal of infectious diseases.

Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity.

J. Hauber, S. Venz, C. Scharf, 2012, Journal of proteome research.

Frontiers in Clinical Drug Research-Anti Infectives

J. Hauber, Xiaochen Bo, M. Hornef, 2017 .

In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway

J. Hauber, A. Kaiser, Marcel Krepstakies, 2012, BMC Microbiology.

Linker‐Region Modified Derivatives of the Deoxyhypusine Synthase Inhibitor CNI‐1493 Suppress HIV‐1 Replication

J. Hauber, M. Rarey, J. van Lunzen, 2016, Archiv der Pharmazie.

Formation of Trans-Activation Competent HIV-1 Rev:RRE Complexes Requires the Recruitment of Multiple Protein Activation Domains

J. Hauber, D. Millar, M. Schindler, 2012, PloS one.